Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Russo

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 28, 2014
[Oral hypoglycemic drugs in chronic kidney disease: which limitations in the clinical setting]Antonio Granata, Monica Insalaco, Pierpaolo Di Nicolò, et al.
Cancer Medicine|June 9, 2021
High-dose corticosteroid use and risk of hospitalization for infection in patients treated with immune checkpoint inhibitors--A nationwide register-based cohort studySigne Sørup, Bianka Darvalics, Leo Russo, et al.
Biomimetics (Basel, Switzerland)|September 26, 2025
Deep Learning Models Optimization for Gait Phase Identification from EMG Data During Exoskeleton-Assisted WalkingRoberto Soldi, Bruna Maria Vittoria Guerra, Stefania Sozzi, et al.
Journal of Ovarian Research|September 2, 2020
A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancerDaniel C Beachler, Francois-Xavier Lamy, Leo Russo, et al.
Current Therapeutic Research, Clinical and Experimental|December 9, 2024
US Real-World Effectiveness Study of Nirmatrelvir/Ritonavir in Preventing Hospitalization of High-Risk COVID-19 PatientsMark R Cullen, Xiaofeng Zhou, Scott P Kelly, et al.
European Journal of Pain (London, England)|December 2, 2021
Exploring patient preference heterogeneity for pharmacological treatments for chronic pain: A latent class analysisDavid A Walsh, Marco Boeri, Lucy Abraham, et al.
Clinical Epidemiology|September 30, 2021
Treatment and Survival in Advanced Non-Small Cell Lung Cancer, Urothelial, Ovarian, Gastric and Kidney Cancer: A Nationwide Comprehensive EvaluationSigne Sørup, Bianka Darvalics, Azza Ahmed Khalil, et al.
Cancer Epidemiology|May 26, 2019
Development of predictive models to identify advanced-stage cancer patients in a US healthcare claims databaseDaina B Esposito, Leo Russo, Dina Oksen, et al.
Drug Safety|November 17, 2022
Development and Evaluation of the Algorithm CErtaInty Tool (ACE-IT) to Assess Electronic Medical Record and Claims-based Algorithms' Fit for Purpose for Safety OutcomesSonal Singh, Julie Beyrer, Xiaofeng Zhou, et al.
Molecular Genetics & Genomic Medicine|March 23, 2021
Patients' and caregivers' maximum acceptable risk of death for non-curative gene therapy to treat Duchenne muscular dystrophyHolly L Peay, Ryan Fischer, Brennan Mange, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 28, 2014
[Oral hypoglycemic drugs in chronic kidney disease: which limitations in the clinical setting]Antonio Granata, Monica Insalaco, Pierpaolo Di Nicolò, et al.
Cancer Medicine|June 9, 2021
High-dose corticosteroid use and risk of hospitalization for infection in patients treated with immune checkpoint inhibitors--A nationwide register-based cohort studySigne Sørup, Bianka Darvalics, Leo Russo, et al.
Biomimetics (Basel, Switzerland)|September 26, 2025
Deep Learning Models Optimization for Gait Phase Identification from EMG Data During Exoskeleton-Assisted WalkingRoberto Soldi, Bruna Maria Vittoria Guerra, Stefania Sozzi, et al.
Journal of Ovarian Research|September 2, 2020
A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancerDaniel C Beachler, Francois-Xavier Lamy, Leo Russo, et al.
Current Therapeutic Research, Clinical and Experimental|December 9, 2024
US Real-World Effectiveness Study of Nirmatrelvir/Ritonavir in Preventing Hospitalization of High-Risk COVID-19 PatientsMark R Cullen, Xiaofeng Zhou, Scott P Kelly, et al.
European Journal of Pain (London, England)|December 2, 2021
Exploring patient preference heterogeneity for pharmacological treatments for chronic pain: A latent class analysisDavid A Walsh, Marco Boeri, Lucy Abraham, et al.
Clinical Epidemiology|September 30, 2021
Treatment and Survival in Advanced Non-Small Cell Lung Cancer, Urothelial, Ovarian, Gastric and Kidney Cancer: A Nationwide Comprehensive EvaluationSigne Sørup, Bianka Darvalics, Azza Ahmed Khalil, et al.
Cancer Epidemiology|May 26, 2019
Development of predictive models to identify advanced-stage cancer patients in a US healthcare claims databaseDaina B Esposito, Leo Russo, Dina Oksen, et al.
Drug Safety|November 17, 2022
Development and Evaluation of the Algorithm CErtaInty Tool (ACE-IT) to Assess Electronic Medical Record and Claims-based Algorithms' Fit for Purpose for Safety OutcomesSonal Singh, Julie Beyrer, Xiaofeng Zhou, et al.
Molecular Genetics & Genomic Medicine|March 23, 2021
Patients' and caregivers' maximum acceptable risk of death for non-curative gene therapy to treat Duchenne muscular dystrophyHolly L Peay, Ryan Fischer, Brennan Mange, et al.
Pageof 3